Table 2 Demographic and clinical characteristics of 640 patients enrolled in both the intervention and control groups
Variables | Total (n = 640) | Control (n = 308) | Intervention (n = 332) | P-value** | |
|---|---|---|---|---|---|
n (%) | n (%) | n (%) | |||
Age | Median (IQR) | 31.9 (28.2–35.1) | 31.7 (28.2–34.5) | 32.1 (28.4–35.6) | |
<35 years old | 474 (74.1) | 235 (76.3) | 239 (72.0) | 0.21 | |
≥35 years old | 166 (25.9) | 73 (23.7) | 93 (28.0) | ||
Sex | Male | 452 (70.6) | 216 (70.1) | 236 (71.1) | 0.79 |
Female | 188 (29.4) | 92 (29.9) | 96 (28.9) | ||
Marital status | Single | 195 (30.5) | 89 (28.9) | 106 (32.0) | 0.44 |
Married/divorced | 445 (69.5) | 219 (71.7) | 226 (68.1) | ||
ART-naïve status | Naïve | 606 (94.7) | 289 (45.2) | 317 (49.5) | 0.35 |
Non-naïve | 35 (6.0) | 19 (6.2) | 16 (4.8) | ||
History of OIs* | Yes | 182 (28.4) | 91 (29.5) | 91 (27.4) | 0.55 |
No | 458 (71.6) | 217 (70.5) | 241 (72.6) | ||
Occupation | Employed | 493 (77.0) | 243 (78.9) | 250 (75.3) | 0.31 |
Unemployed | 147 (23.0) | 65 (21.1) | 82 (24.7) | ||
Time to be known infected ≥6 months | <6 months HIV- | 156 (24.4) | 69 (22.4) | 87 (26.2) | 0.31 |
449 (70.0) | 220 (71.0) | 229 (69.0) | |||
HIV transmission route (self-reported) | IV Drug use | 297 (46.4) | 136 (44.2) | 161 (48.5) | 0.27 |
Sexual and others | 343 (53.6) | 172 (55.8) | 171 (51.5) | ||
History of IDU | Yes | 337 (52.7) | 151 (49.0) | 186 (56.0) | 0.08 |
No | 303 (47.3) | 157 (51.0) | 146 (44.0) | ||
Viral hepatitis | Yes | 207 (33.7) | 92 (31.1) | 115 (36.2) | 0.18 |
No | 407 (36.3) | 204 (68.9) | 203 (63.8) | ||
History of TB | Yes treatment | 99 (15.5) | 53 (17.2) | 46 (13.9) | 0.24 |
No | 541 (84.5) | 255 (82.8) | 286 (86.1) | ||
Having an HIV infected family member | Yes | 256 (40.0) | 132 (42.9) | 124 (37.3) | 0.09 |
No | 384 (60) | 176 (57.1) | 208 (62.7) | ||
WHO clinical stage | Clinical stage 1 or 2 | 298 (46.6) | 142 (46.1) | 156 (47.0) | 0.82 |
Clinical stage 3 or 4 | 342 (53.4) | 166 (53.9) | 176 (53.0) | ||
BMI” | 18+ kg/m2 | 409 (64.0) | 188 (61.0) | 221 (66.7) | 0.15 |
<18 kg/m2 | 231 (36.0) | 120 (39.0) | 111 (33.3) | ||
Hemoglobin level | <100 g/L | 73 (11.4) | 33 (10.7) | 40 (12.0) | 0.61 |
≥100 g/L | 520 (81.2) | 253 (82.1) | 267 (80.4) | ||
CD4 counts | Median (IQR) | 83 (29–176) | 82 (27–183) | 84 (30–168) | 0.90 |
<100 cells/μl | 359 (56.1) | 172 (55.8) | 187 (56.3) | ||
>100 cells/μl | 281 (43.9) | 136 (44.2) | 145 (43.7) | ||
VL at baseline (copies/ml) | <100.000 | 426 (66.7) | 209 (67.9) | 217 (65.6) | 0.54 |
≥100,000 | 213 (33.3) | 99 (32.1) | 114 (34.4) | ||
regimen | D4T/3TC/NVP ART^ | 533 (83.3) | 258 (83.8) | 275 (82.8) | 0.75 |
Other regimens | 107 (16.7) | 50 (16.2) | 57 (17.2) | ||
Clinics | Halong CDC | 307 (48.0) | 168 (54.5) | 139 (41.9) | 0.001 |
Other clinics | 333 (52.0) | 140 (45.5) | 193 (58.1) | ||